Carcinoembryonic antigen (CEA) is one of the most commonly used tumor markers in serum immunoassay determinations of carcinoma. Members of the CEACAM (carcinoembryonic antigen-related cell adhesion molecule) family contain a single N domain, with structural homology to the immunoglobulin variable domains, followed by a variable number of immunoglobulin constantlike A and/or B domains. CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1), also known as BGP or BGP1, is a 526 amino acid protein that exists as seven alternatively spliced isoforms, some of which localize to the cell membranes, while others are secreted. One of several members of the CEACAM family, CEACAM1 contains one Ig-like V-type domain and three Ig-like C2-type domains and is thought to play a role in a variety of cellular activities, including angiogenesis, apoptosis, arrangement of tissue threedimensional structure and modulation of innate and adaptive immune responses. Additionally, CEACAM1 is underexpressed in colorectal cancers, suggesting a role in tumor suppression.
200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
SDS-PAGE Analysis of Purified CEACAM1 Mouse Monoclonal Antibody (CEACAM1/12659). Confirmation of Purity and Integrity of Antibody.
Western Blot Analysis of SK-MEL-28 lysate using CEACAM1 Mouse Monoclonal Antibody (CEACAM1/12659).
Formalin-fixed, paraffin-embedded human colon stained with CEACAM1 Mouse Monoclonal Antibody (CEACAM1/12659). Inset: PBS instead of primary antibody, secondary only negative control.
* VAT and and shipping costs not included. Errors and price changes excepted
